Presidio Management Group X LLC, 10% Owner at eFFECTOR Therapeutics, Inc. (EFTR), sold 142,590 shares at $6.44 ($936K) on 2021-12-01, disclosed to the SEC on 2021-12-01.
Open-market sale of $936k EFTR by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.70 | 799 | $5K | 0.6% |
| 2 | $6.70 | 24,965 | $167K | 17.9% |
| 3 | $6.70 | 24,965 | $167K | 17.9% |
| 4 | $6.53 | 850 | $6K | 0.6% |
| 5 | $6.53 | 26,559 | $173K | 18.5% |
| 6 | $6.53 | 26,559 |
| $173K |
| 18.5% |
| 7 | $6.44 | 597 | $4K | 0.4% |
| 8 | $6.44 | 18,648 | $120K | 12.8% |
| 9 | $6.44 | 18,648 | $120K | 12.8% |
| Total | $6.57 avg | 142,590 | $936K | 100% |
| Filing → |